Prelude Therapeutics Ownership | Who Owns Prelude Therapeutics?
Prelude Therapeutics Ownership Summary
Prelude Therapeutics is owned by 35.78% institutional investors, 11.34% insiders, and 52.88% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.36% of PRLD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.31% of its assets in Prelude Therapeutics shares.
PRLD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Prelude Therapeutics | 35.78% | 11.34% | 52.88% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 10.91M | 14.36% | $8.83M |
| Baker bros. advisors lp | 10.12M | 13.32% | $8.19M |
| Boxer capital | 2.57M | 3.39% | $9.79M |
| Blackrock | 1.07M | 1.41% | $4.07M |
| Price t rowe associates inc /md/ | 1.03M | 1.36% | $1.31M |
| Vanguard group | 1.01M | 1.33% | $1.29M |
| Renaissance | 634.50K | 0.84% | $808.99K |
| Acadian asset management | 540.57K | 0.71% | $436.00K |
| Millennium management | 462.56K | 0.61% | $589.76K |
| Blackrock funding, inc. /de | 432.56K | 0.57% | $350.11K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Boxer capital | 2.57M | 0.52% | $9.79M |
| Orbimed advisors | 10.91M | 0.22% | $8.83M |
| Baker bros. advisors lp | 10.12M | 0.08% | $8.19M |
| Shay capital | 75.00K | 0.01% | $60.70K |
| Bridgeway capital management | 111.00K | 0.00% | $141.53K |
| Cantor fitzgerald, l. p. | 211.86K | 0.00% | $171.48K |
| Xtx topco | 42.57K | 0.00% | $34.46K |
| Renaissance | 634.50K | 0.00% | $808.99K |
| Two sigma advisers, lp | 300.00K | 0.00% | $382.50K |
| Acadian asset management | 540.57K | 0.00% | $436.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 634.50K | 0.00% | 437.60K |
| Millennium management | 462.56K | 0.00% | 302.03K |
| Two sigma advisers, lp | 300.00K | 0.00% | 252.10K |
| Cantor fitzgerald, l. p. | 211.86K | 0.00% | 211.86K |
| Two sigma investments, lp | 231.84K | 0.00% | 174.91K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -3.77M |
| Exoduspoint capital management, lp | - | - | -921.62K |
| Avidity partners management lp | - | - | -890.00K |
| Blackrock funding, inc. /de | 432.56K | - | -615.17K |
| Massachusetts financial services co /ma/ | - | - | -494.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Cantor fitzgerald, l. p. | 211.86K | 0.00% | 211.86K | $171.48K |
| Shay capital | 75.00K | 0.01% | 75.00K | $60.70K |
| Susquehanna group, llp | 72.80K | - | 72.80K | $92.82K |
| Y-intercept (hong kong) | 47.79K | 0.00% | 47.79K | $38.68K |
| Bnp paribas arbitrage, snc | 20.57K | - | 20.57K | $26.23K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -1.00 |
| Capital performance advisors llp | -8.00 |
| Srs capital advisors | -19.00 |
| Highmark wealth management | -50.00 |
| Russell investments group | -76.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 49 | -14.04% | 27,188,001 | -4.17% | 35 | 2.57% | 19 | -9.52% | 23 | -4.17% |
| Mar 31, 2025 | 57 | -6.56% | 30,474,260 | -5.26% | 40 | 2.23% | 22 | -35.29% | 24 | 118.18% |
| Dec 31, 2024 | 22 | -69.01% | 4,265,950 | -88.07% | 5 | 0.25% | 12 | -67.57% | 4 | -78.95% |
| Sep 30, 2024 | 71 | 14.52% | 35,754,682 | 5.42% | 47 | 2.35% | 37 | 48.00% | 19 | -9.52% |
| Jun 30, 2024 | 62 | 6.90% | 33,917,495 | -0.86% | 44 | 1.39% | 25 | 13.64% | 21 | -4.55% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 720.43K | 1.31% | - |
| Vanguard Total Stock Mkt Idx Inv | 705.02K | 1.25% | -15.41K |
| T. Rowe Price Health Sciences | 661.22K | 1.17% | -24.89K |
| Biotech Growth Ord | 346.50K | 0.61% | - |
| MFS New Discovery I | 327.70K | 0.60% | - |
| T. Rowe Price Small-Cap Value | 168.61K | 0.31% | -90.00 |
| Fidelity Small Cap Index | 144.77K | 0.26% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 142.55K | 0.25% | -64.96K |
| MFS VIT New Discovery Init | 104.99K | 0.19% | - |
| Fidelity Extended Market Index | 104.83K | 0.19% | -274.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 25, 2025 | Combs Andrew | Chief Chemistry Officer | Buy | $69.25K |
| Mar 25, 2025 | Vaddi Krishna | CEO | Buy | $467.44K |
| Mar 20, 2025 | Vaddi Krishna | CEO | Buy | $3.95K |
| Mar 21, 2025 | Vaddi Krishna | CEO | Buy | $10.96K |
| Mar 17, 2025 | Vaddi Krishna | CEO | Buy | $6.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | 8 | - |
| 2024 Q4 | 7 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
PRLD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools